Speech-Language Pathologists in Brooksville, KY Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Mrs. Shelby Woods, B.H.S., M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2388 Willow Lenoxburg Rd, Brooksville, KY 41004 Phone: 606-782-4721 |
Mrs. Dawn Ann Cooper, M.A. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 897 John England Rd, Brooksville, KY 41004 Phone: 859-588-8160 Fax: 606-724-2448 |
Mrs. Sue Anne Case, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 242 Garrett Ave, Brooksville, KY 41004 Phone: 606-735-3654 Fax: 606-735-2527 |
Mallory B Staggs, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2388 Willow Lenoxburg Rd, Brooksville, KY 41004 Phone: 606-782-5435 |
News Archive
Health Canada accepts Seattle Genetics' ADCETRIS NDS for review
Seattle Genetics, Inc. announced today that the validation period is complete and Health Canada has accepted for review its New Drug Submission (NDS) for the use of ADCETRIS (brentuximab vedotin) in relapsed Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma.
TRIA Beauty receives OTC clearance from FDA for hand-held blue light device
TRIA Beauty, the leader in light-based therapeutic beauty devices, today announced it received over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a hand-held blue light device designed for at-home use.
New report outlines a race-free approach to diagnose kidney diseases
The National Kidney Foundation and the American Society of Nephrology Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases has released its final report, which outlines a new race-free approach to diagnose kidney disease.
Scientific, ethical issues involved in studies of drug safety after FDA approval to be evaluated
The director and a core faculty member of the Johns Hopkins Berman Institute of Bioethics have been appointed co-chairs of an Institute of Medicine committee that will evaluate the scientific and ethical issues involved in studies of drug safety after FDA approval.
› Verified 4 days ago